openPR Logo
Press release

Biopharma PEG's Azide PEG Series for Pharmaceuticals

01-17-2024 08:54 AM CET | Science & Education

Press release from: Biopharma PEG Scientific Inc

Biopharma PEG, a leading innovator in polyethylene glycol (PEG) derivatives, proudly introduces its featured Azide PEG series, which can be used in drug development, click chemistry, ADCs (Antibody Drug Conjugates), PROTACs (Proteolysis Targeting Chimeras), and beyond.
This Azide PEG features monodispersed PEGs such as N3-PEG4-OH, N3-PEG3-COOH, N3-PEG11-NH2, N3-PEG3-NHS ester, 2-((Azido-PEG8-carbamoyl)methoxy)acetic acid, polydispersed Azide PEGs like mPEG-N3, N3-PEG-N3, Silane-PEG-N3, SH-PEG-N3, and multi-arm azide PEGs such as 4-ArmPEG-N3.
Key Applications of Biopharma PEG's Azide PEG Series:
ADCs and PROTACs: The Azide PEG series plays a pivotal role in the development of ADCs, connecting antibodies with cytotoxic drugs, and in PROTACs, facilitating the degradation of specific proteins for innovative therapeutic approaches.
Drug Delivery: Biopharma PEG's Azide PEGs enhance drug solubility, stability, and controlled release, making them indispensable in advanced drug delivery systems.
Click Chemistry: Serving as key components in click chemistry, these compounds enable precise bioconjugation reactions, fostering the synthesis of diverse molecular structures.
Dr. Zhang, Chief Scientist at Biopharma PEG, expressed the company's commitment to driving innovation, stating, "Our Azide PEG series represents a significant leap forward in empowering researchers with unparalleled tools. From targeted drug delivery to advancing bioconjugation strategies, these compounds are poised to catalyze breakthroughs in biomedical research."
Biopharma PEG's Azide PEG series is a testament to the company's dedication to advancing the capabilities of researchers and propelling the biomedical field into new realms of innovation.
For more information about Biopharma PEG's Azide PEG series and other groundbreaking products, please visit https://www.biochempeg.com/.

Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Website: https://www.biochempeg.com/

Biopharma PEG stands as a leading supplier of polyethylene glycol (PEG) derivatives, committed to advancing biomedical research by delivering high-quality, innovative products tailored to the evolving needs of scientists and researchers. The company's dedication to excellence underscores its pivotal role in shaping the future of biomedical research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharma PEG's Azide PEG Series for Pharmaceuticals here

News-ID: 3353752 • Views:

More Releases from Biopharma PEG Scientific Inc

FDA Approval of Vepdegestrant Highlights the Growing Importance of Linker Design in PROTAC Drug Discovery
FDA Approval of Vepdegestrant Highlights the Growing Importance of Linker Design …
Watertown, MA - The recent FDA approval of vepdegestrant (VeppanuTM, ARV-471) marks a significant milestone for targeted protein degradation, bringing the first PROTAC therapy into clinical practice for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. Beyond validating the PROTAC modality, this achievement has renewed attention on one of its most critical design elements-the linker. Unlike conventional small-molecule inhibitors, PROTACs (Proteolysis Targeting Chimeras) eliminate disease-causing proteins by recruiting an
Biopharma PEG to Present PEG Derivatives at TIDES USA 2026 in Boston
Biopharma PEG to Present PEG Derivatives at TIDES USA 2026 in Boston
Biopharma PEG will exhibit at TIDES USA 2026 in Boston this May, where the company will introduce its latest portfolio of high-purity PEG derivatives for drug delivery, bioconjugation, and related pharmaceutical research applications. The event will be held at the Hynes Convention Center in Boston, Massachusetts, USA, from May 11-14, 2026. Biopharma PEG will welcome visitors at Booth 826 to discuss product selection, application needs, and supply support for research and
Biopharma PEG Offers In-Stock Monodispersed PEGs at Competitive Prices
Biopharma PEG Offers In-Stock Monodispersed PEGs at Competitive Prices
Biopharma PEG Scientific Inc. announced the availability of a broad range of in-stock monodispersed PEG derivatives at highly competitive prices, supporting researchers working in antibody-drug conjugates (ADCs), nanoparticle and LNP delivery systems, diagnostics, and biomaterials. Biopharma PEG specializes in PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, offered in both GMP and non-GMP grades. By keeping key monodispersed PEGs on the shelf and ready to ship, the company aims to help
Biopharma PEG Highlights the Critical Role of PEG-Lipid Nanoparticles in RNA The …
Watertown, MA, September 26, 2025 - In the past decade, lipid nanoparticles (LNPs) have emerged as the premier delivery vehicle for RNA-based medicines, powering the success of both siRNA drugs and mRNA vaccines. A key component of these systems is PEG-lipids, specialized polyethylene glycol (PEG) derivatives that stabilize nanoparticles, extend circulation time, and enhance safety. Why PEG-Lipids Are Essential RNA molecules are inherently unstable in the bloodstream, where they are rapidly degraded

All 5 Releases


More Releases for Azide

Potassium Azide Production Cost Analysis Report 2025: Feasibility Study and Prof …
Setting up a potassium azide production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Potassium Azide Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a potassium azide
Detailed Report on Potassium Azide Plant Setup Cost: Profit Margin
Setting up a potassium azide manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Potassium Azide Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a potassium
Sodium Azide Market Trends : Fabulous Opportunities for Growth Through 2030 | TC …
CALIFORNIA, (UNITED STATES) - According to QYResearch New Study Report 'Sodium Azide Market 2024' provides a comprehensive analysis of the industry with market insights will definitely facilitate to increase the knowledge and decision-making skills of the business, thus providing an immense opportunity for growth. Finally, this will increase the return rate and strengthen the competitive advantage within. Since it's a personalised market report, the services are catered to the particular
What's driving the Sodium Azide Market growth? Key Players are: TCI Chemicals, F …
Big Market Research has added a report, titled, “Sodium Azide.” The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2014-2019, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2024. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends is
Sodium Azide Market 2017- TCI Chemicals, Fluorochem, SHINYA CHEM
This report studies Sodium Azide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Request for Sample(No Cost for sample) @ https://goo.gl/SyaIXq Top Manufacturers Analysis of This Report TCI Chemicals Fluorochem SHINYA CHEM The market research report explores the Sodium Azide market across the globe along with major regions and countries. The
Global Sodium Azide Market – Industry Analysis and Future Forecast by 2021 wit …
Qyresearchreports include new market research report “Global Sodium Azide Market Professional Survey Report 2017″ to its huge collection of research reports. This research report gives a definitive review on the Sodium Azide as in light of a segmented pattern. Entry variables managed in the report incorporate the distinctive services or products offered by the market players alongside the free market activity scales for current market measurements, in addition to anticipated